FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005874808> ?p ?o ?g. }

• W2005874808 abstract "Skin cancer, the majority of which is non-melanoma skin cancer (NMSC), is the most common type of cancer in the US. The rate of NMSC is increasing mainly due to depletion of the ozone layer and increased exposure to ultraviolet radiation. To reduce the risk of skin cancer, it is recommended to all individuals to limit sun exposure and use sunscreens. Despite these efforts, the incidence of NMSC continues to rise. Novel chemopreventive targets and nontoxic agents are needed. Epidemiological studies identified an association of psychosocial factors such as chronic stress or depression with cancer onset and progression. These factors are partly mediated by activation of the sympathetic nervous system which results in release of norepinephrine and epinephrine, the effects of which are mediated through the alpha- and beta-adrenergic receptors (alpha- and beta-AR). Further, the use of beta-AR antagonists (beta-blockers) has been associated with reduced cancer incidence. However, whether beta-blockers have chemopreventive activity or whether beta-ARs contribute to carcinogenesis is unknown. To determine whether agonizing or antagonizing beta-ARs affect skin cell transformation, we tested the beta-AR agonist isoproterenol (Iso) and antagonist carvedilol on epidermal growth factor (EGF)-mediated transformation of JB6 P+ cells (a skin cell model to study tumor promotion). The cells were treated with EGF (10 ng/mL) plus 0.1 µM or 1.0 µM Iso, yet no effect was observed. However, treatment with carvedilol dose-dependently inhibited the formation of EGF-induced soft agar colonies. Such effect was not caused by growth inhibition, because cytotoxicity and inhibition of cell proliferation were not observed for tested concentrations. Next, the expression of beta1-, 2- and 3-AR was determined in JB6 cells using RT-PCR. The results showed that only beta2-AR was detectable. We also determined whether beta-ARs are expressed in other types of cancer. In tissues derived from a rat model of 7, 12-dimethylbenz[α]anthracene (DMBA)-induced mammary cancer, expression of beta1- and 2-AR was up-regulated in tumors in comparison with normal tissues. The human cancer cell lines A549 and MDA-MB-231 also express beta2-AR. To determine the in vivo chemopreventive activity of carvedilol, we used a skin hyperplasia model in SENCAR mice induced by topical treatment with 100 nM DMBA twice a week for four weeks. Carvedilol was tested topically (5 and 10 µM) or orally (5 and 20 mg/kg), beginning at two weeks before the first dose of DMBA, three times a week, for six weeks. DMBA alone increased the epidermal thickness from the average of 77.8 + 13.6 nm in normal skin to 294 + 49.7 nm in DMBA-treated skin. Both topical and oral carvedilol treatment inhibited DMBA-induced hyperplasia (P Citation Format: Andy Chang, Mandy Liu, Steven Yeung, Jijun Hao, Cyrus Parsa, Robert Orlando, Bradley Andresen, Ying Huang. The chemopreventive effects of carvedilol on skin carcinogenesis. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1256. doi:10.1158/1538-7445.AM2014-1256" @default.
• W2005874808 created "2016-06-24" @default.
• W2005874808 creator A5009668864 @default.
• W2005874808 creator A5018714255 @default.
• W2005874808 creator A5025393961 @default.
• W2005874808 creator A5036337768 @default.
• W2005874808 creator A5041519459 @default.
• W2005874808 creator A5046138088 @default.
• W2005874808 creator A5067060393 @default.
• W2005874808 creator A5080076598 @default.
• W2005874808 date "2014-09-30" @default.
• W2005874808 modified "2023-09-25" @default.
• W2005874808 title "Abstract 1256: The chemopreventive effects of carvedilol on skin carcinogenesis" @default.
• W2005874808 doi "https://doi.org/10.1158/1538-7445.am2014-1256" @default.
• W2005874808 hasPublicationYear "2014" @default.
• W2005874808 type Work @default.
• W2005874808 sameAs 2005874808 @default.
• W2005874808 citedByCount "0" @default.
• W2005874808 crossrefType "proceedings-article" @default.
• W2005874808 hasAuthorship W2005874808A5009668864 @default.
• W2005874808 hasAuthorship W2005874808A5018714255 @default.
• W2005874808 hasAuthorship W2005874808A5025393961 @default.
• W2005874808 hasAuthorship W2005874808A5036337768 @default.
• W2005874808 hasAuthorship W2005874808A5041519459 @default.
• W2005874808 hasAuthorship W2005874808A5046138088 @default.
• W2005874808 hasAuthorship W2005874808A5067060393 @default.
• W2005874808 hasAuthorship W2005874808A5080076598 @default.
• W2005874808 hasConcept C121608353 @default.
• W2005874808 hasConcept C126322002 @default.
• W2005874808 hasConcept C134018914 @default.
• W2005874808 hasConcept C199360897 @default.
• W2005874808 hasConcept C2776174256 @default.
• W2005874808 hasConcept C2777658100 @default.
• W2005874808 hasConcept C2777789703 @default.
• W2005874808 hasConcept C2778198053 @default.
• W2005874808 hasConcept C2780122803 @default.
• W2005874808 hasConcept C2780591200 @default.
• W2005874808 hasConcept C41008148 @default.
• W2005874808 hasConcept C502942594 @default.
• W2005874808 hasConcept C555283112 @default.
• W2005874808 hasConcept C71924100 @default.
• W2005874808 hasConcept C98274493 @default.
• W2005874808 hasConceptScore W2005874808C121608353 @default.
• W2005874808 hasConceptScore W2005874808C126322002 @default.
• W2005874808 hasConceptScore W2005874808C134018914 @default.
• W2005874808 hasConceptScore W2005874808C199360897 @default.
• W2005874808 hasConceptScore W2005874808C2776174256 @default.
• W2005874808 hasConceptScore W2005874808C2777658100 @default.
• W2005874808 hasConceptScore W2005874808C2777789703 @default.
• W2005874808 hasConceptScore W2005874808C2778198053 @default.
• W2005874808 hasConceptScore W2005874808C2780122803 @default.
• W2005874808 hasConceptScore W2005874808C2780591200 @default.
• W2005874808 hasConceptScore W2005874808C41008148 @default.
• W2005874808 hasConceptScore W2005874808C502942594 @default.
• W2005874808 hasConceptScore W2005874808C555283112 @default.
• W2005874808 hasConceptScore W2005874808C71924100 @default.
• W2005874808 hasConceptScore W2005874808C98274493 @default.
• W2005874808 hasLocation W20058748081 @default.
• W2005874808 hasOpenAccess W2005874808 @default.
• W2005874808 hasPrimaryLocation W20058748081 @default.
• W2005874808 hasRelatedWork W1966097020 @default.
• W2005874808 hasRelatedWork W1971323295 @default.
• W2005874808 hasRelatedWork W2019874145 @default.
• W2005874808 hasRelatedWork W2024414043 @default.
• W2005874808 hasRelatedWork W2025771146 @default.
• W2005874808 hasRelatedWork W2043115773 @default.
• W2005874808 hasRelatedWork W2057110760 @default.
• W2005874808 hasRelatedWork W2078958553 @default.
• W2005874808 hasRelatedWork W2085261889 @default.
• W2005874808 hasRelatedWork W2097683230 @default.
• W2005874808 hasRelatedWork W2316077971 @default.
• W2005874808 hasRelatedWork W2326686174 @default.
• W2005874808 hasRelatedWork W2334258518 @default.
• W2005874808 hasRelatedWork W2346749300 @default.
• W2005874808 hasRelatedWork W2488793792 @default.
• W2005874808 hasRelatedWork W2739098833 @default.
• W2005874808 hasRelatedWork W2792937627 @default.
• W2005874808 hasRelatedWork W2801576059 @default.
• W2005874808 hasRelatedWork W2996483961 @default.
• W2005874808 hasRelatedWork W3094004672 @default.
• W2005874808 isParatext "false" @default.
• W2005874808 isRetracted "false" @default.
• W2005874808 magId "2005874808" @default.
• W2005874808 workType "article" @default.